MapLight Therapeutics Inc
MPLTHealthcare|Biotechnology|USA
$39.28
-0.48 (-1.21%)
Tangible Book
$8.84
Upcoming Data Readouts (3)
Dec 2027
Est. completion
P2Psychosis Associated With Alzheimer's Disease
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
NCT06887192n=300
Mar 2029
Est. completion
P2Psychosis Associated With Alzheimer's Disease
An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis
NCT07459660n=210
Feb 2030
Est. completion
P2Schizophrenia
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
NCT07459647n=500